Author

Lauriane E. Quenee

Observed names: L. E. Quenee, L. Quénée, Lauriane E Quenee, Lauriane QUENEE, Lauriane Quenee, Lauriane Quénée

Institution: California Institute of Technology

Observed institutions: California Institute of Technology, Argonne National Laboratory, Centre National de la Recherche Scientifique, Inserm, Université Joseph Fourier, Université de Lille, Centre Hospitalier Universitaire de Grenoble, Centre Hospitalier Universitaire de Lille, University of Chicago, Center for Infection and Immunity of Lille, Translational Innovation in Medicine and Complexity

OpenAlex ID: A5111972512

Combined sacB -Based Negative Selection and cre-lox Antibiotic Marker Recycling for Efficient Gene Deletion in Pseudomonas Aeruginosa

2005 · Lauriane Quénée, Danièle Lamotte, et al. · BioTechniques · 87

Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia*

2011 · Rozenn Le Berre, Sophie Nguyen, et al. · Critical Care Medicine · 75

Yersinia pestis caf1Variants and the Limits of Plague Vaccine Protection

2008 · Lauriane E. Quenee, Claire A. Cornelius, et al. · Infection and Immunity · 71

Hereditary Hemochromatosis Restores the Virulence of Plague Vaccine Strains

2012 · L. E. Quenee, T. M. Hermanas, et al. · The Journal of Infectious Diseases · 65

PDF

Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines

2011 · Lauriane E. Quenee, Nancy A. Ciletti, et al. · Vaccine · 64

Immunization with Recombinant V10 Protects Cynomolgus Macaques from Lethal Pneumonic Plague

2008 · Claire A. Cornelius, Lauriane E. Quenee, et al. · Infection and Immunity · 61

Considerations for Infectious Disease Research Studies Using Animals.

2017 · Lesley A Colby, Lauriane E Quenee, et al. · Europe PMC (PubMed Central) · 51

Anti-tumor Immunotherapy via Antigen Delivery from a Live Attenuated Genetically Engineered Pseudomonas aeruginosa Type III Secretion System-Based Vector

2006 · Olivier Epaulard, Bertrand Toussaint, et al. · Molecular Therapy · 50

PDF

Plague vaccines and the molecular basis of immunity againstYersinia pestis

2009 · Lauriane E. Quenee, Olaf Schneewind · Human Vaccines · 40

PDF

Amino acid residues 196–225 of LcrV represent a plague protective epitope

2009 · Lauriane E. Quenee, Bryan J. Berube, et al. · Vaccine · 34

Orf1/SpcS Chaperones ExoS for Type Three Secretion by Pseudomonas aeruginosa

2008 · Da-Kang SHEN, Lauriane QUENEE, et al. · Biomedical and Environmental Sciences · 31

Yersinia pestisIS1541Transposition Provides for Escape from Plague Immunity

2009 · Claire A. Cornelius, Lauriane E. Quenee, et al. · Infection and Immunity · 26

Protective Immunity Against Plague

2007 · Claire Cornelius, Olaf Schneewind, et al. · Advances in experimental medicine and biology · 25

High-Yield Production of Secreted Active Proteins by the Pseudomonas aeruginosa Type III Secretion System

2008 · M. Derouazi, B. Toussaint, et al. · Applied and Environmental Microbiology · 20

Plague in Guinea Pigs and Its Prevention by Subunit Vaccines

2011 · Lauriane E. Quenee, Nancy Ciletti, et al. · American Journal Of Pathology · 19

PDF

Polymorphisms in the lcrV Gene of Yersinia enterocolitica and Their Effect on Plague Protective Immunity

2012 · Nathan C. Miller, Lauriane E. Quenee, et al. · Infection and Immunity · 16

Vaccine Protection against Bacillus cereus-Mediated Respiratory Anthrax-Like Disease in Mice

2013 · So-Young Oh, Hannah Maier, et al. · Infection and Immunity · 9

Ubiquitin‐Yop hybrids as probes for post‐translational transport by the Yersinia type III secretion pathway

2007 · Lauriane E. Quenee, Olaf Schneewind · Molecular Microbiology · 3

Mécanismes de la sécrétion des toxines ExoS et ExoT par le système de sécrétion de type III de Pseudomonas aeruginosa : séquence d'adressage et rôle de la chaperonne SpcS

2004 · Lauriane E. Quenee · OpenGrey (Institut de l'Information Scientifique et Technique)

Works count: 22

Citation count: 747

H-index: 16

I10-index: 16